Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
76 hedge funds and large institutions have $8.75M invested in Ampio Pharmaceuticals Inc. in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 10 closing their positions.
557% more call options, than puts
Call options by funds: $138K | Put options by funds: $21K
39% more capital invested
Capital invested by funds: $6.3M → $8.75M (+$2.45M)
17% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 12
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
1% more funds holding
Funds holding: 75 → 76 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$345K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$240K |
| 3 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
+$235K |
| 4 |
HIS
Harvest Investment Services
Oakbrook Terrace,
Illinois
|
+$47.1K |
| 5 |
BJL
Brighton Jones LLC
Seattle,
Washington
|
+$23.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WWM
Western Wealth Management
Golden,
Colorado
|
-$263K |
| 2 |
Millennium Management
New York
|
-$36.8K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$22.2K |
| 4 |
Bank of New York Mellon
New York
|
-$21K |
| 5 |
CCMW
Cypress Capital Management (Wyoming)
Sheridan,
Wyoming
|
-$18.1K |
AMPE Hedge Fund Activity: Q4 2019 in Review
76 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2019, worth a combined $8.75M — up 39% from $6.3M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new AMPE positions and 10 closed out — a net gain of 1 holder — while 14 added to existing stakes and 12 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $345K. The largest seller was Western Wealth Management, exiting entirely with an estimated $263K sold.
- 76 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2019, up from 75 in Q3 2019.
- Funds reported $8.75M of Ampio Pharmaceuticals Inc. stock for Q4 2019, up 39% quarter-over-quarter.
- 11 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2019 and 10 closed out, a net change of +1 holder.
- The largest Ampio Pharmaceuticals Inc. buyer in Q4 2019 was Susquehanna International Group, an estimated $345K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q4 2019 was Western Wealth Management, an estimated $263K sold.
Based on aggregated 13F filings for Q4 2019.